Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinomaMoritz Jesinghaus, Wilko Weichert, Melanie Boxberg et al.|British Journal of Cancer|2019Cited by 15
Budesonide Orodispersible Tablets are Highly Effective for Treatment of Active Eosinophilic Esophagitis: Results from a Randomized, Double-Blind, Placebo-Controlled, Pivotal Multicenter Trial (EOS-1)Alfredo J. Lucendo, Alex Straumann, Jamal Hayat et al.|Gastroenterology|2017Cited by 13
951a – Budesonide Orodispersible Tablets are Highly Effective to Maintain Clinico-Histological Remission in Adult Patients with Eosinophilic Esophagitis: Results from the 48-Weeks, Double-Blind, Placebo-Controlled, Pivotal Eos-2 TrialAlfredo J. Lucendo, Alex Straumann, Stephan Miehlke et al.|Gastroenterology|2019Cited by 10
309 - Prolongation of Eosinophilic Esophagitis Treatment with Budesonide Orodispersible Tablets for Incomplete Responder is Effective and Safe: Results from a 6-Weeks Open-Label Treatment Phase of the Pivotal Trial EOS-1Alfredo J. Lucendo, Alex Straumann, Stephan Miehlke et al.|Gastroenterology|2018Cited by 3
Sa1145 - Predictors for Early Versus Delayed Response to Budesonide Orodispersible Tablets in Eosinophilic Esophagitis Treatment: A Subgroup Analysis from the Pivotal Trial Eos-1Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke et al.|Gastroenterology|2018Cited by 2